Burkavage Brian 4
4 · IO Biotech, Inc. · Filed Nov 24, 2023
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Burkavage Brian
Chief Accounting Officer
Transactions
- Purchase
Common Stock
2023-11-22$1.03/sh+5,000$5,175→ 11,500 total - Purchase
Common Stock
2023-11-21$0.99/sh+5,000$4,950→ 6,500 total
Footnotes (1)
- [F1]The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.